I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Heart failure and chronic kidney disease manifestation and ..:
Birkeland, Kåre I
;
Bodegard, Johan
;
Eriksson, Jan W
...
Diabetes, obesity and metabolism, 1462-8902, 2020, 22:9, s. 1607-1618. , 2020
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423708
RT Journal T1
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes : A large multinational cohort study
UL https://suche.suub.uni-bremen.de/peid=base-ftuppsalauniv:oai:DiVA.org:uu-423708&Exemplar=1&LAN=DE A1 Birkeland, Kåre I A1 Bodegard, Johan A1 Eriksson, Jan W A1 Norhammar, Anna A1 Haller, Hermann A1 Linssen, Gerard C. M A1 Banerjee, Amitava A1 Thuresson, Marcus A1 Okami, Suguru A1 Garal-Pantaler, Elena A1 Overbeek, Jetty A1 Mamza, Jil Billy A1 Zhang, Ruiqi A1 Yajima, Toshitaka A1 Komuro, Issei A1 Kadowaki, Takashi PB Uppsala universitet, Klinisk diabetologi och metabolism; Oslo Univ Hosp, Oslo, Norway.;Univ Oslo, Oslo, Norway; AstraZeneca, Oslo, Norway; Dept Med, Cardiol Unit, Solna, Sweden.;Karolinska Inst, Stockholm, Sweden.;St Gorans Univ Hosp, Stockholm, Sweden; Hannover Med Sch, Div Nephrol, Hannover, Germany; Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands; UCL, Inst Hlth Informat, London, England.;Univ Coll London Hosp, Dept Cardiol, London, England; Statisticon AB, Uppsala, Sweden; AstraZeneca, Osaka, Japan; Team Gesundheit GmbH, Essen, Germany; PHARMO Inst Drug Outcomes Res CRS, Utrecht, Netherlands; AstraZeneca, Luton, Beds, England; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Prevent Diabet & Lifestyle Related Dis, Tokyo, Japan.;Teikyo Univ, Mizonokuchi Hosp, Dept Metab & Nutr, Kawasaki, Kanagawa, Japan YR 2020 K1 diabetic nephropathy K1 heart failure K1 macrovascular disease K1 observational study K1 type 2 diabetes K1 SGLT2 inhibitor K1 Endocrinology and Diabetes K1 Endokrinologi och diabetes JF Diabetes, obesity and metabolism, 1462-8902, 2020, 22:9, s. 1607-1618 LK http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423708 DO http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423708 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)